{
  "paper_metadata": {
    "pmid": "35627273",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant c.401A>G (p.Tyr134Cys) and penetrance data from affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.401A>G",
      "protein_notation": "p.Tyr134Cys",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 5,
        "demographics": "Various ages, including 15 to 44 years, all Chinese",
        "phenotype": "Familial Amyloid Polyneuropathy (FAP) with ocular manifestations"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 3,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 60.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1 (III:4)",
          "age_at_evaluation": 44,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Progressive bilateral floaters, vitreous opacities, BCVA 20/125 OD and 20/200 OS",
          "evidence_sentence": "Case 1 (III:4) was a 44-year-old woman complaining of progressive bilateral floaters that persisted for several months."
        },
        {
          "individual_id": "Case 2 (III:1)",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Progressive blurred vision, significant vitreous opacities, BCVA light perception OD and 20/800 OS",
          "evidence_sentence": "Case 2 (III:1) was the cousin of case 1. He was 40 years old and complained of progressive blurred vision in his left eye for over 2 years."
        },
        {
          "individual_id": "Case 3 (III:2)",
          "age_at_evaluation": 43,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Decreased vision in left eye, significant vitreous opacities, BCVA 20/20 OD and 20/400 OS",
          "evidence_sentence": "Case 3 (III:2) was a 43-year-old brother of case 2. He complained of decreased vision of the left eye for several months."
        },
        {
          "individual_id": "Case 4 (IV:1)",
          "age_at_evaluation": 22,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "Bilateral BCVAs of 20/20, mild venous tortuosity",
          "evidence_sentence": "Case 4 (IV:1) was the 22-year-old nephew of cases 2 and 3, and case 5 (IV:3) was the 15-year-old son of case 2."
        },
        {
          "individual_id": "Case 5 (IV:3)",
          "age_at_evaluation": 15,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "Bilateral BCVAs of 20/20, mild venous tortuosity in left eye",
          "evidence_sentence": "Case 5 (IV:3) was the 15-year-old son of case 2."
        }
      ],
      "functional_data": {
        "summary": "The variant c.401A>G (p.Tyr134Cys) is associated with amyloid deposition in the retina and other ocular manifestations.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in the family, as affected individuals are confirmed to carry the mutation.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the importance of monitoring asymptomatic carriers for potential ocular manifestations.",
      "key_quotes": [
        "The results highlight the amyloid deposition of mutant TTR in the optic disc and retina, even in the asymptomatic stage.",
        "Patients with FAP carrying the c.401A>G (p.Tyr134Cys) mutation have a higher prevalence of vitreous opacities."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}